Sinusoidal obstruction syndrome in children with B-acute lymphoblastic leukemia (B-ALL) treated with inotuzumab ozogamicin: Results from the ITCC-059 trial - Poll - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Sinusoidal Obstruction Syndrome in Pediatric Patients with B-acute Lymphoblastic Leukemia Treated with Inotuzumab Ozogamicin: Findings from the ITCC-059 Study

  • By

  • Angela Iannicelli

  • Franco Locatelli

  • Yilin Jiang

  • Anneke Ammerlaan

  • Susana Rives

  • Inge M. van der Sluis

  • Caroline Lindemans

  • Bella Bielorai

  • Cristina Díaz de Heredia

  • Andrej Lissat

  • Claudia Rossig

  • Arnaud Petit

  • Fanny Rialland Battisti

  • Carmelo Rizzari

  • Anna B. Nilsson

  • Benedicte Bruno

  • Alba Rubio San Simón

  • Lucie Sramkova

  • Gernot Engstler

  • Uta Dirksen

  • Benoit Brethon

  • Barbara De Moerloose

  • Marlène Pasquet

  • Peter McCarthy

  • Karsten Nysom

  • Carine Halfon-Domenech

  • Nicoletta Bertorello

  • Jochen Buechner

  • Peter Bader

  • C. Michel Zwaan

  • Erica Brivio

  • August 21, 2026

Share

Original Source(s)

Related Content